Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224118045> ?p ?o ?g. }
- W4224118045 endingPage "109438" @default.
- W4224118045 startingPage "109438" @default.
- W4224118045 abstract "Evidence regarding the acceptability of contingency management is limited. We investigated the willingness of people who inject drugs to participate in a randomised controlled trial (RCT) involving financial incentives to initiate HCV treatment.ETHOS Engage is an observational cohort study of people with a history of injecting drug use who either injected in the past six months or receive opioid agonist therapy (OAT) in Australia. We assessed willingness to participate in a RCT with financial incentives and factors associated with preference for entire incentive ($60) at first clinic visit versus delayed incentive with logistic regression.93% (593/635) of eligible participants agreed to participate in an RCT with financial incentives of which 24% were Aboriginal or Torres Strait Islander, 84% had completed secondary school, and 59% injected drugs in the prior month. Willingness to participate in an RCT increased by amount offered: unspecified (72%), $20 (75%), $60 (80%), and $100 (85%). The preferred incentive distribution method over three clinical visits was entire incentive at first clinical visit (32%). Among those with a preferred distribution method (n = 369), factors associated with entire incentive at first clinic visit were being Aboriginal or Torres Strait Islander (aOR 1.75; 95% CI 1.05-2.94), completion of secondary school (aOR 0.46; 95% CI 0.26-0.83) and mainly injected heroin in month prior (aOR 1.82; 95% CI 1.03-3.20).Most participants were willing to participate in an RCT involving financial incentives to initiate treatment but differed regarding distribution. Study findings inform implementation of incentives in clinical practice." @default.
- W4224118045 created "2022-04-19" @default.
- W4224118045 creator A5004010648 @default.
- W4224118045 creator A5008145587 @default.
- W4224118045 creator A5010049089 @default.
- W4224118045 creator A5010998752 @default.
- W4224118045 creator A5011208640 @default.
- W4224118045 creator A5015270011 @default.
- W4224118045 creator A5028544789 @default.
- W4224118045 creator A5032658269 @default.
- W4224118045 creator A5042359443 @default.
- W4224118045 creator A5045529959 @default.
- W4224118045 creator A5052909853 @default.
- W4224118045 creator A5052916430 @default.
- W4224118045 creator A5054648799 @default.
- W4224118045 creator A5068150121 @default.
- W4224118045 creator A5076492591 @default.
- W4224118045 creator A5078715807 @default.
- W4224118045 creator A5081120679 @default.
- W4224118045 creator A5081388535 @default.
- W4224118045 date "2022-06-01" @default.
- W4224118045 modified "2023-09-27" @default.
- W4224118045 title "Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatment" @default.
- W4224118045 cites W1486426261 @default.
- W4224118045 cites W1968164111 @default.
- W4224118045 cites W1975612181 @default.
- W4224118045 cites W2001401696 @default.
- W4224118045 cites W2044421611 @default.
- W4224118045 cites W2065962849 @default.
- W4224118045 cites W2066261281 @default.
- W4224118045 cites W2086887894 @default.
- W4224118045 cites W2095695118 @default.
- W4224118045 cites W2097787837 @default.
- W4224118045 cites W2098623632 @default.
- W4224118045 cites W2115695512 @default.
- W4224118045 cites W2131792659 @default.
- W4224118045 cites W2132910897 @default.
- W4224118045 cites W2139182374 @default.
- W4224118045 cites W2172036914 @default.
- W4224118045 cites W2185218296 @default.
- W4224118045 cites W2228001519 @default.
- W4224118045 cites W2393834324 @default.
- W4224118045 cites W2462927291 @default.
- W4224118045 cites W2510907818 @default.
- W4224118045 cites W2519823516 @default.
- W4224118045 cites W2611584903 @default.
- W4224118045 cites W2620924543 @default.
- W4224118045 cites W2626716901 @default.
- W4224118045 cites W2884128589 @default.
- W4224118045 cites W2890778396 @default.
- W4224118045 cites W2898222507 @default.
- W4224118045 cites W2966463951 @default.
- W4224118045 cites W3027264454 @default.
- W4224118045 cites W3089080866 @default.
- W4224118045 cites W3165664034 @default.
- W4224118045 cites W3188878117 @default.
- W4224118045 doi "https://doi.org/10.1016/j.drugalcdep.2022.109438" @default.
- W4224118045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35430521" @default.
- W4224118045 hasPublicationYear "2022" @default.
- W4224118045 type Work @default.
- W4224118045 citedByCount "4" @default.
- W4224118045 countsByYear W42241180452022 @default.
- W4224118045 countsByYear W42241180452023 @default.
- W4224118045 crossrefType "journal-article" @default.
- W4224118045 hasAuthorship W4224118045A5004010648 @default.
- W4224118045 hasAuthorship W4224118045A5008145587 @default.
- W4224118045 hasAuthorship W4224118045A5010049089 @default.
- W4224118045 hasAuthorship W4224118045A5010998752 @default.
- W4224118045 hasAuthorship W4224118045A5011208640 @default.
- W4224118045 hasAuthorship W4224118045A5015270011 @default.
- W4224118045 hasAuthorship W4224118045A5028544789 @default.
- W4224118045 hasAuthorship W4224118045A5032658269 @default.
- W4224118045 hasAuthorship W4224118045A5042359443 @default.
- W4224118045 hasAuthorship W4224118045A5045529959 @default.
- W4224118045 hasAuthorship W4224118045A5052909853 @default.
- W4224118045 hasAuthorship W4224118045A5052916430 @default.
- W4224118045 hasAuthorship W4224118045A5054648799 @default.
- W4224118045 hasAuthorship W4224118045A5068150121 @default.
- W4224118045 hasAuthorship W4224118045A5076492591 @default.
- W4224118045 hasAuthorship W4224118045A5078715807 @default.
- W4224118045 hasAuthorship W4224118045A5081120679 @default.
- W4224118045 hasAuthorship W4224118045A5081388535 @default.
- W4224118045 hasConcept C105867702 @default.
- W4224118045 hasConcept C118552586 @default.
- W4224118045 hasConcept C126322002 @default.
- W4224118045 hasConcept C162324750 @default.
- W4224118045 hasConcept C168563851 @default.
- W4224118045 hasConcept C175444787 @default.
- W4224118045 hasConcept C23131810 @default.
- W4224118045 hasConcept C2780665704 @default.
- W4224118045 hasConcept C29122968 @default.
- W4224118045 hasConcept C512399662 @default.
- W4224118045 hasConcept C71924100 @default.
- W4224118045 hasConceptScore W4224118045C105867702 @default.
- W4224118045 hasConceptScore W4224118045C118552586 @default.
- W4224118045 hasConceptScore W4224118045C126322002 @default.
- W4224118045 hasConceptScore W4224118045C162324750 @default.
- W4224118045 hasConceptScore W4224118045C168563851 @default.